Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Roche and Glycart to discover next-generation therapeutic antibodies

Sep. 27, 2004

U.S. Army to evaluate Pharming's recombinant human fibrinogen product

Sep. 22, 2004

Nuvelo and Kirin Brewery expand research and development collaboration

Sep. 17, 2004

Lilly advances therapeutic antibody into clinic

Sep. 16, 2004

Proof of concept in Genmab/Roche collaboration

Sep. 16, 2004

Mirus Bio enters into research agreement with Genzyme

Sep. 15, 2004

Crucell signs PER.C6 license agreement with MorphoSys

Sep. 9, 2004

Series B financing at MAP Pharmaceuticals to advance inhaled drug products

Sep. 9, 2004

Valentis expands licensing agreement with Genzyme

Sep. 8, 2004

ChemDiv and Yale University receive STTR grant

Sep. 1, 2004

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...